Search results for "kings college london"

The Agilent Protein 80 kits provide a reliable way to assess protein concentration, identity, and purity. It eliminates handling of SDS-PAGE slab gels, staining or imaging steps.

Agilent offers dispersive SPE kits that are specifically designed to remove lipids from high-fat samples, though they can be used with any sample type. The sorbent will pull interfering lipids from samples while leaving analytes behind. The final polishing step removes excess water and improves analyte partitioning. These kits contain 1 g of preweighted sorbent in 15 mL centrifuge tubes. They can easily accommodate the aliquot…

Lipofectamine™ Transfection Reagent is one of Thermo Fisher Scientific's first-generation, cationic-lipid transfection reagents formulated for the transfection of DNA into eukaryotic cells. Lipofectamine™ Transfection Reagent is a trusted, value reagent with many years of cited use in thousands of publications and with many cell lines.

CytoOne 35 x 10 mm TC dish, 10/sleeve, 300/case Beveled outer edges help you grasp CytoOne 35 x 10 mm dishes without accidentally displacing the lids. Tissue culture treatment promotes optimum cell attachment and growth. Growth area: 9.6 cm2; working volume: 2 ml; inner diameter: 3.5 cm. • Sturdy, flat bases resist bowing and warping • Optical clarity provides distortion-free microscopy • Vented lids improve gas exchange • Sta…

Replacement battery cover for the Falcon pipet controller.

Thermo Scientific 1-Step Human In Vitro Protein Expression Kits enable the translation and post-transcriptional modification of full-length proteins from mRNA or plasmid templates with yields of up to 100 µg/mL per reaction. The Human IVT Kits are unique HeLa cell lysate-based protein expression systems for in vitrotranslation or coupled transcription/translation reactions. Protein expression is performed in a single 90-min…

Cell-based assay expert shares how to overcome your cell-based challenges and drive the development of cutting-edge biotherapeutics

Trial results presented at ECCMID show potential of Actiphage for risk stratification in those with latent TB